Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain

Neurobiology of Aging

Volumn 17, Issue 3, 1996, Pages 349-357

  Klunk, W E ^a   Xu, C ^a   Panchalingam, K ^a   McClure, R J ^a   Pettegrew, J W ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

3 aminopropylphosphon; Alzheimer's disease; Amino acids; GABA; In vitro; Membranes; Myo inositol; N acetylaspartate; Nuclear magnetic resonance; Perchloric acid extracts; Phosphocholine; Phosphodiesters; Phosphoethanolamine; Phosphomonoesters; Phosphorus; Proton

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; N ACETYLASPARTIC ACID; PERCHLORIC ACID; PHOSPHOMONOESTER; PHOSPHORUS; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRADATION; HUMAN; HUMAN TISSUE; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; AGED; BRAIN; CEREBELLUM; FEMALE; FRONTAL LOBE; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CEREBELLUM; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PERCHLORIC ACID;

EID: 0029665411     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(96)00035-8     Document Type: Article

References (41)

1. Bancher, C.; Braak, H.; Fischer, P.; Jellinger, K. A. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci. Lett. 162:179-182; 1993.
2. 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13:23-31; 1989.
3. Blessed, G.; Tomlinson, B. E.; Roth, M. The association between quantitative measures of dementia and senile changes in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 114:797-811; 1968.
4. Bottomley, P. A. The trouble with spectroscopy papers. Radiology 181:344-350; 1991.
5. Bottomley, P. A.; Cousins, J. P.; Pendrey, D. L.; Wagle, W. A.; Hardy, C. J.; Eames, F. A.; McCaffrey, R. J.; Thompson, D. A. Alzheimer dementia: Quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy. Radiology 183:695-699; 1992.
6. Brenner, R. E.; Munro, P. M.; Williams, S. C.; Bell, J. D.; Barker, G. J.; Hawkins, C. P.; Landon, D. N.; McDonald, W. I. The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio. Magn. Reson. Med. 29:737-745; 1993.
7. Brown, G. G.; Garcia, J. H.; Gdowski, J. W.; Levine, S. R.; Helpern, J. A. Altered brain energy metabolism in demented patients with multiple subcortical ischemic lesions. Working hypotheses. Arch. Neurol. 50:384-388; 1993.
8. 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 39:1423-1427; 1989.
9. Cooper, J. R.; Bloom, F. E.; Roth, R. H. The biochemical basis of neuropharmacology. 4th ed. New York: Oxford University Press; 1982:
10. Cuenod, C.; Kaplan, D. B.; Michot, J.; Jehenson, P.; Leroy-Willig, A.; Forette, F.; Syrota, A.; Boller, F. Phospholipid abnormalities in early Alzheimer's disease. Arch. Neurol. 52:89-94; 1995.
11. Davie, C. A.; Hawkins, C. P.; Barker, G. J.; Brennan, A.; Tofts, P. S.; Miller, D. H.; McDonald, W. I. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117:49-58; 1994.
12. 1H magnetic resonance spectroscopic imaging. J. Cereb. Blood Flow Metab. 14:373-382; 1994.
13. Henneberry, R. C. The role of neuronal energy in the neurotoxicity of excitatory amino acids. Neurobiol. Aging 10:611-613; 1989.
14. Henneberry, R. C.; Novelli, A.; Vigano, M. A.; Reilly, J. A.; Cox, J. A.; Lysko, P. G. Energy-related neurotoxicity at the NMDA receptor: A possible role in Alzheimer's disease and related disorders. Prog. Clin. Biol. Res. 317:143-156; 1989.
15. Kamada, K.; Houkin, K.; Aoki, T.; Koiwa, M.; Kashiwaba, T.; Iwasaki, Y.; Abe, H. Cerebral metabolic changes in delayed carbon monoxide sequelae studied by proton MR spectroscopy. Neuroradiology 36:104-106; 1994.
16. Khachaturian, Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1097-1105; 1985.
17. b receptor: A comparison of phosphoethanolamine and related GABA analogs. Mol. Chem. Neuropathol. 26:15-30; 1995.
18. Klunk, W. E.; Panchalingam, K.; Moossy, J.; McClure, R. J.; Pettegrew, J. W. N-Acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study. Neurology 42:1578-1585; 1992.
19. Klunk, W. E.; Xu, C. J.; Panchalingam, K.; McClure, R. J.; Pettegrew, J. W. Analysis of magnetic resonance spectra by mole percent: Comparison to absolute units. Neurobiol. Aging 15:133-140; 1994.
20. Koh, J. Y.; Yang, L. L.; Cotman, C. W. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:315-320; 1990.
21. Mann, D. M. A. The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations. Mech. Ageing Dev. 31:213-255; 1985.
22. Mattson, M. P.; Cheng, B.; Davis, D.; Bryant, K.; Lieberburg, I.; Rydel, R. E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:376-389; 1992.
23. McKee, A. C.; Kosik, K. S.; Kowall, N. W. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30:156-165; 1991.
24. Meyerhoff, D. J.; MacKay, S.; Gorssman, N.; et al. Effects of normal aging and Alzheimer's disease on cerebral H-1 metabolites. Soc. Magn. Reson. Med. 1931; 1992.
25. Miller, B. L.; Moats, R. A.; Shonk, T.; Ernst, T.; Woolley, S.; Ross, B. D. Alzheimer's disease: Depiction of increased cerebral myoinositol with proton MR spectroscopy. Radiology 187:433-437; 1993.
26. Moats, R. A.; Ernst, T.; Shonk, T. K.; Ross, B. D. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn. Reson. Med. 32:110-115; 1994.
27. Moossy, J.; Zubenko, G.; Martinez, J.; et al. Bilateral symmetry of morphologic lesions in Alzheimer's disease. Arch. Neurol. 45:251-254; 1988.
28. Murphy, D. G.; Bottomley, P. A.; Salerno, J. A.; DeCarli, C.; Mentis, M. J.; Grady, C. L.; Teichberg, D.; Giacometti, K. R.; Rosenberg, J. M.; Hardy, C. J.; et al. An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET. Arch. Gen. Psychiatry 50:341-349; 1993.
29. Nitsch, R. M.; Blusztajn, J. K.; Pittas, A. G.; Slack, B. E.; Growdon, J. H.; Wurtman, R. J. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA 89:1671-1675; 1992.
30. Novelli, A.; Reilly, J. A.; Lysko, P. G.; Henneberry, R. C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451:205-212; 1988.
31. 31P NMR shows decreased brain ATP utillization is correlated with severity of dementia in Alzheimer's disease. Neurology 41 (Suppl. 1):269; 1991.
32. 31P Nuclear magnetic resonance study of the brain in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 47:235-248; 1988.
33. Pettegrew, J. W.; Panchalingam, K.; Klunk, W. E.; McClure, R. J.; Muenz, L. R. Alterations of cerebral metabolism in probable Alzheimer's disease; A preliminary study. Neurobiol. Aging 15:117-132; 1994.
34. Pettegrew, J. W.; Panchalingam, K.; Moossy, J.; Martinez, J.; Rao, G.; Boller, F. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease. Arch. Neurol. 45:1093-1096; 1988.
35. 31P Nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Alzheimer's disease. J. Neural Transm. Suppl. 24:261-268; 1987.
36. 13C NMR to the study of glutamate metabolism in cultured glial cells and human brain in vivo. Biochimie 73:93-97; 1991.
37. Shonk, T. K.; Moats, R. A.; Gifford, P.; Michaelis, T.; Mandigo, J. C.; Izumi, J.; Ross, B. D. Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 195:65-72; 1995.
38. 31P magnetic resonance spectroscopy in Alzheimer's and Pick's disease. Neurobiol. Aging 14:85-92; 1993.
39. Terry, R. D.; Peck, A.; DeTeresa, R.; Schechter, R.; Horoupian, D. S. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10:184-192; 1981.
40. Urenjak, J.; Williams, S. R.; Gadian, D. G.; Noble, M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59:55-61; 1992.
41. Wilcock, G. K.; Esiri, M. M. Plaques, tangles, and dementia: A quantitative study. J. Neurol. Sci. 56:343-356; 1982.